CXCR inhibitor USL311, Purity ≥98%

Cat. No.: X23-10-ZQ685

CXCR inhibitor USL311, Purity ≥98%

Synonym: 1373268-67-7; USL-311; USL311; 6-[Hexahydro-4-[1-(1-methylethyl)-4-piperidinyl]-1H-1,4-diazepin-1-yl]-N-4-pyridinyl-2-pyridinecarboxamide; 2BTG5MX2Q2; 6-(4-(1-Isopropylpiperidin-4-yl)-1,4-diazepan-1-yl)-N-(pyridin-4-yl)picolinamide; 6-[4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepan-1-yl]-N-pyridin-4-ylpyridine-2-carboxamide; CXCR inhibitor

  • CAS Number: 1373268-67-7
  • Compound CID: 56961879
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
USL311 targets the chemokine receptors CXCR, which are part of the GPCR family. It targets CXCR4.
Molecular Weight
422.58
Molecular Formula
C24H34N6O
Targets
CXCR4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
USL311 can be used to study its effects as an antagonist of the P2X7 receptor, useful in immunological and neurological research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.